Carregant...
Comparative assessment of budesonide‐MMX and mesalamine in active, mild‐to‐moderate ulcerative colitis: A systematic review and network meta‐analysis
AIMS: The comparative efficacy, safety and tolerability of budesonide‐MMX and oral mesalamine in active, mild‐to‐moderate ulcerative colitis (UC) are unclear. We conducted a network meta‐analysis to fill this evidence gap. METHODS: We searched PubMed, Scopus, Embase, the Cochrane Library, clinical t...
Guardat en:
| Publicat a: | Br J Clin Pharmacol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6783624/ https://ncbi.nlm.nih.gov/pubmed/31269287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14051 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|